Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paul

Showing results (751-760 of 763) with videos related to

Pageof 77
Sort By:
Schizophrenia (Heidelberg, Germany)|May 21, 2025
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerationsDiana O Perkins, Clark D Jeffries, Scott R Clark, et al.
Social Psychiatry and Psychiatric Epidemiology|January 5, 2021
The association between migrant status and transition in an ultra-high risk for psychosis populationBrian O'Donoghue, Hellen Geros, Holly Sizer, et al.
The New England Journal of Medicine|March 1, 2023
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced MelanomaSapna P Patel, Megan Othus, Yuanbin Chen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 22, 2021
Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort StudyFerdy S van Geest, Stefan Groeneweg, Erica L T van den Akker, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 11, 2019
Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI studyStephanie Menghini-Müller, Erich Studerus, Sarah Ittig, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Normative modeling of brain morphometry in Clinical High-Risk for PsychosisShalaila S Haas, Ruiyang Ge, Ingrid Agartz, et al.
JAMA Psychiatry|October 11, 2023
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis, Shalaila S Haas, Ruiyang Ge, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2020
Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort studyStefan Groeneweg, Ferdy S van Geest, Ayhan Abacı, et al.
Molecular Psychiatry|October 22, 2025
Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR StudySiwei Liu, Ingrid Agartz, Paul Allen, et al.
JAMA Psychiatry|May 5, 2021
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis, Maria Jalbrzikowski, Rebecca A Hayes, et al.
Pageof 77

Showing results (751-760 of 763) with videos related to

Sort By:
Pageof 77
Schizophrenia (Heidelberg, Germany)|May 21, 2025
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerationsDiana O Perkins, Clark D Jeffries, Scott R Clark, et al.
Social Psychiatry and Psychiatric Epidemiology|January 5, 2021
The association between migrant status and transition in an ultra-high risk for psychosis populationBrian O'Donoghue, Hellen Geros, Holly Sizer, et al.
The New England Journal of Medicine|March 1, 2023
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced MelanomaSapna P Patel, Megan Othus, Yuanbin Chen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 22, 2021
Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort StudyFerdy S van Geest, Stefan Groeneweg, Erica L T van den Akker, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 11, 2019
Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI studyStephanie Menghini-Müller, Erich Studerus, Sarah Ittig, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Normative modeling of brain morphometry in Clinical High-Risk for PsychosisShalaila S Haas, Ruiyang Ge, Ingrid Agartz, et al.
JAMA Psychiatry|October 11, 2023
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis, Shalaila S Haas, Ruiyang Ge, et al.
The Lancet. Diabetes & Endocrinology|June 20, 2020
Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort studyStefan Groeneweg, Ferdy S van Geest, Ayhan Abacı, et al.
Molecular Psychiatry|October 22, 2025
Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR StudySiwei Liu, Ingrid Agartz, Paul Allen, et al.
JAMA Psychiatry|May 5, 2021
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis, Maria Jalbrzikowski, Rebecca A Hayes, et al.
Pageof 77